scholarly journals Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides

Author(s):  
Jiao Luo ◽  
Meiling Zheng ◽  
Bo Jiang ◽  
Chao Li ◽  
Shuju Guo ◽  
...  
Author(s):  
Monika Rakse ◽  
Chandrabose Karthikeyan ◽  
Narayana Subbiah Hari Narayana Moorthy ◽  
Ram Kishore Agrawal

Background: Protein Tyrosine Phosphatase 1B (PTP1B) is an attractive target for antidiabetic drug discovery owing to its pivotal role as a negative regulator of insulin and leptin signaling. Objective: The objective of this research is to design, synthesize, and evaluate some acetamido benzoic acid derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors with therapeutic potential for Type II diabetes. Methods: 3-(2-(benzo[d]thiazol-2-ylthio)acetamido)benzoic acid derivatives 4(a-j) were synthesized and characterized by employing spectral studies. All the synthesized compounds were screened for in vitro PTP1B inhibitory activity and the most potent compound in the series was also evaluated for in vivo anti-hyperglycemic activity using STZ induced diabetic Wistar rat model. Molecular docking studies were also performed with the most potent analog using FlexX docking algorithm to delineate its binding mode to the active site of the PTP1B. Results and Discussion: Among all the synthesized compounds, 3-(2-(benzo[d]thiazol-2-ylthio)acetamido)-4- methylbenzoic acid (4f) displayed good PTP1B inhibitory activity with an IC50 value of 11.17 μM. The compound also exhibited good anti-hyperglycemic efficacy in streptozotocin induced diabetic Wistar rats. Docking studies with 4f revealed the compound bound in the catalytic and second aryl binding site of the PTP1B. Conclusion: Overall, compound 4f with good in vitro PTP1B inhibitory potency and in vivo antihyperglycemic efficacy would be a valuable lead molecule for the development of acetamido benzoic acid based PTP1B inhibitors with antidiabetic potential.


2001 ◽  
Vol 173 (1-2) ◽  
pp. 109-120 ◽  
Author(s):  
Xin-Yuan Wang ◽  
Katrin Bergdahl ◽  
Anna Heijbel ◽  
Charlotta Liljebris ◽  
John E. Bleasdale

1994 ◽  
Vol 14 (8) ◽  
pp. 5523-5532
Author(s):  
D R Stover ◽  
K A Walsh

We describe a potential regulatory mechanism for the transmembrane protein-tyrosine phosphatase CD45. Phosphorylation on both tyrosine and serine residues in vitro results in an activation of CD45 specifically toward one artificial substrate but not another. The activation of these kinases appears to be order dependent, as it is enhanced when phosphorylation of tyrosine precedes that of serine but phosphorylation in the reverse order yields no activation. Any of four protein-tyrosine kinases tested, in combination with the protein-serine/threonine kinase, casein kinase II, was capable of mediating this activation in vitro. The time course of phosphorylation of CD45 in response to T-cell activation is consistent with the possibility that this regulatory mechanism is utilized in vivo.


Author(s):  
Chang-An Geng ◽  
Zhen-Tao Deng ◽  
Qian Huang ◽  
Chun-Lei Xiang ◽  
Ji-Jun Chen

AbstractTen 3,5-dimethylcoumarins (1–6 and 8‒11) involving six new ones (1–6), together with a known 3-methylcoumarin (7), were isolated from the aerial parts of three Chelonopsis plants, C. praecox, C. odontochila, and C. pseudobracteata. The structures of the new compounds were determined by extensive HRESIMS, 1D and 2D NMR spectroscopic analyses. According to the substitution at C-5, these coumarins were classified into 5-methyl, 5-hydroxymethyl, 5-formyl, and 5-nor types. All the isolates were assayed for their inhibition on α-glucosidase, protein tyrosine phosphatase 1B, and T-cell protein tyrosine phosphatase in vitro. Graphic Abstract


Author(s):  
Nursamsiar Nursamsiar ◽  
Akbar Awaluddin ◽  
Megawati Megawati ◽  
Yulita M. Soko ◽  
Muhammad Aswad

Senyawa aglikon kurkuligosida A memiliki struktur yang mirip dengan senyawa licoagrochalcone yang terbukti memiliki aktivitas penghambatan yang kuat secara in vitro pada Protein Tyrosine Phosphatase 1B (PTP1B), yang dianggap sebagai target terapeutik untuk pengobatan diabetes melitus tipe 2. Penelitian ini bertujuan untuk mengetahui interaksi antara senyawa aglikon kurkuligosida A dan turunannya dengan PTP1B menggunakan metode simulasi docking. Simulasi docking dilakukan dengan menggunakan perangkat lunak AutoDock 4.2. Hasil docking menunjukan semua senyawa yang diuji dapat berinteraksi dengan sisi aktif PTP1B. Interaksi terbaik ditunjukkan oleh senyawa 31 (3,5-dihidroksibensil-3,5-dinitrobenzoate), senyawa 39 (3,5-dihidroksibensil-4-nitrobenzoate) dan senyawa 52 (4-hidroksibensil-4-nitro bensoat) dengan nilai energi bebas ikatan berturut-turut –9,40 kkal/mol ; –9,19 kkal/mol dan –9,03 kkal/mol. Ketiga senyawa tersebut memiliki interaksi dengan sisi aktif PTP1B dengan residu asam amino Ser216 dan Arg221. Semua senyawa turunan aglikon kurkuligosida A yang diuji juga memiliki pola pengikatan yang sama dengan ligan alami pada PTP1B.


Author(s):  
Thomas Lubben ◽  
Jill Clampit ◽  
Michael Stashko ◽  
James Trevillyan ◽  
Michael R. Jirousek

ChemMedChem ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. 815-826 ◽  
Author(s):  
Stefanie Grosskopf ◽  
Chris Eckert ◽  
Christoph Arkona ◽  
Silke Radetzki ◽  
Kerstin Böhm ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document